Dados B3 › IGTI11 × AMER3
IGTI11 × AMER3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | IGTI11 | AMER3 | year |
|---|---|---|---|
| ROE | 13.0% | -5.6% | 2025 |
| ROIC | 15.1% | 3.4% | 2025 |
| ROA | 6.5% | -1.6% | 2025 |
| Gross margin | 75.0% | 27.0% | 2025 |
| EBIT margin | 75.5% | 2.7% | 2025 |
| Net margin | 39.2% | -2.2% | 2025 |
| Net debt/EBITDA | 1.77x | 0.83x | 2025 |
| Current ratio | 2.49x | 1.67x | 2025 |
| Revenue growth (1y) | 20.3% | -1.2% | 2025 |
| Revenue growth (5y CAGR) | 17.1% | 4.0% | 2025 |
| Piotroski F-Score | 6/9 | 3/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | IGTI11 | AMER3 | year |
|---|---|---|---|
| P/E | 20.32x | -3.81x | 2025 |
| P/B | 2.54x | 0.22x | 2025 |
| EV/EBITDA | 11.23x | 1.73x | 2025 |
| FCF yield | — | 34.5% | 2025 |
Numbers on this page are live. Data version 2026-09-14-etfs · page generated 2026-09-20 16:58 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-14-etfs · page generated 2026-09-20 16:58 UTC. If this does not match /saude, you are reading a cached copy.